Abstract |
Currently, there is a need for novel, biocompatible, and effective neuroprotectants for the treatment of neurodegenerative diseases and brain injury associated with oxidative damage. Here, we developed nucleotide-based neuroprotectants acting dually as antioxidants and P2Y-R agonists. To improve the potency, selectivity, and metabolic stability of ATP/ ADP, we substituted adenine C2-position by Cl and Pα/Pβ position by borano group, 6-9. Nucleotides 6-9 inhibited oxidation in cell-free systems (Fe(II)-H2O2), as detected by ESR (IC50 up to 175 μM), and ABTS assay (IC50 up to 40 μM). They also inhibited FeSO4-induced oxidative stress in PC12 cells (IC50 of 80-200 nM). 2-Cl-ADP(α-BH3), 7a, was found to be the most potent P2Y1-R agonist currently known (EC50 7 nM) and protected primary cortical neurons from FeSO4 insult (EC50 170 nM). In addition, it proved to be metabolically stable in human blood serum (t(1/2) 7 vs 1.5 h for ADP). Hence, we propose 7a as a highly promising neuroprotectant.
|
Authors | Sagit Azran, Daniel Förster, Ortal Danino, Yael Nadel, Georg Reiser, Bilha Fischer |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 56
Issue 12
Pg. 4938-52
(Jun 27 2013)
ISSN: 1520-4804 [Electronic] United States |
PMID | 23751098
(Publication Type: Journal Article)
|
Chemical References |
- Antioxidants
- Biocompatible Materials
- Neuroprotective Agents
- Nucleotides
- Purinergic P2Y Receptor Agonists
- Reactive Oxygen Species
- Receptors, Purinergic P2Y
|
Topics |
- Animals
- Antioxidants
(chemistry, metabolism, pharmacology, toxicity)
- Biocompatible Materials
(chemistry, metabolism, pharmacology, toxicity)
- Drug Design
- Drug Stability
- Humans
- Hydrolysis
- Models, Molecular
- Neuroprotective Agents
(chemistry, metabolism, pharmacology, toxicity)
- Nucleotides
(chemistry, metabolism, pharmacology, toxicity)
- PC12 Cells
- Protein Conformation
- Purinergic P2Y Receptor Agonists
(chemistry, metabolism, pharmacology, toxicity)
- Rats
- Reactive Oxygen Species
(metabolism)
- Receptors, Purinergic P2Y
(chemistry, metabolism)
|